Stephen Machatha, Chief Development Officer at Aldeyra Therapeutics, Inc. (ALDX), sold 47,999 shares at $3.41 ($161K) on 2024-03-11, disclosed to the SEC on 2024-03-12.
Open-market sale of $161k ALDX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 18,231 | $62K | 38.7% |
| 2 | $3.41 | 18,231 | $62K | 38.7% |
| 3 | $3.16 | 11,537 | $36K | 22.7% |
| Total | $3.35 avg | 47,999 | $161K | 100% |
| Filing → |